PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
March 03, 2011 | ISSUE NUMBER 189 VOL 8

Pipeline
Late-Stage Pipeline Review
Will 2011 be a more promising year for new molecular entities? A review of Big Pharma's late-stage pipeline shows what might lie ahead.

Europe
New Counterfeiting Measures Prompt European Show of Unity
The EU’s proposed new rules concerning counterfeiting are winning applause from all member states.

Legal
Bruesewitz vesus Wyeth: A Dubious Victory for Patients?
In a closely watched case before the US Supreme Court, vaccine manufacturers have won increased protection from liability. Pfizer has hailed the decision a victory for public health, but is it?

Global
Promoting Wellness in Mexico
Pharm Exec looks at the work of the Workplace Wellness & Prevention Council.

// Ron Wall joins the Advanstar team in the newly created position of Executive Vice President, Pharmaceutical/Science. Wall’s focus will be to combine Advanstar’s CBI conference business and its Pharmaceutical business, by tapping into the resources of both in order to accelerate their growth. // Dr. David E. Wheadon, Senior Vice President, scientific and regulatory affairs for the Pharmaceutical Research and Manufacturers of America (PhRMA), joined the Board of Directors of The Make-A-Wish Foundation of America (Phoenix). // Martha R. Feller, PhD, has rejoined Kendle (Cincinnati) as Vice President and Global Head, Study Startup, effective immediately. // Scott Weintraub, founding principle of Healthcare Regional Marketing, a firm specializing in pharmaceutical regional marketing solutions, has been selected for the 2010 Outstanding Leadership Recognition Award by the US Leaders and Entrepreneur’s Association (USLEA). // Acucela (Seattle) has appointed Ghanshyam Patil, Ph.D. to the position of Vice President, Research & Development. Dr. Patil will lead the direction of the company’s early pipeline programs in retinopathy of prematurity, Stargardt disease, and diabetic retinopathy, as well as evaluate new therapeutic areas.

March 22-23: iPharma Connect — Digitally Connecting with Patients, Physicians and Payers
Philadelphia, PA


April 8-10: Asian Oncology Summit 2011
Hong Kong


May 5: Healthcare Businesswomen's Association Woman of the Year
Fairfield, NJ



 
FindPharma  
Search  

Survey
Are you considering making changes to your sales force?
Click To Vote
 
 
Quick Links

Read the new issue of Pharm Exec Global Digest here

Samsung and Quintiles in $266 million Biologicals Venture

Europe Launches New Initiative to Tackle Neglected Tropical Diseases


Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive